We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
(-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the β<sub>1</sub>-adrenoceptor.
- Authors
Sarsero, Doreen; Russell, Fraser D.; Lynham, James A.; Rabnott, Glenn; Yang, Ian; Fong, Kwun M.; Li Li; Kaumann, Alberto J.; Molenaar, Peter
- Abstract
Two forms of the activated β1-adrenoceptor exist, one that is stabilized by (-)-noradrenaline and is sensitive to blockade by (-)-propranolol and another which is stabilized by partial agonists such as (-)-pindolol and (-)-CGP 12177 but is relatively insensitive to (-)-propranolol. We investigated the effects of stimulation of the propranolol-resistant β1-adrenoceptor in the human heart. Myocardium from non-failing and failing human hearts were set up to contract at 1 Hz. In right atrium from non-failing hearts in the presence of 200 nM (-)-propranolol, (-)-CGP 12177 caused concentration-dependent increases in contractile force (–logEC50[M] 7.3±0.1, Emax 23±1% relative to maximal (-)-isoprenaline stimulation of β1- and β2-adrenoceptors, n=86 patients), shortening of the time to reach peak force (–logEC50[M] 7.4±0.1, Emax 37±5%, n=61 patients) and shortening of the time to reach 50% relaxation (t50%, –logEC50[M] 7.3±0.1, Emax 33±2%, n=61 patients). The potency and maxima of the positive inotropic effects were independent of Ser49Gly- and Gly389Arg-β1-adrenoceptor polymorphisms but were potentiated by the phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (–logEC50[M] 7.7±0.1, Emax 68±6%, n=6 patients, P<0.0001). In the presence of (-)-propranolol and 3-isobutyl-1-methylxanthine, the potency (–logEC50[M] 7.4±0.1, P=0.0013, n=9 patients) but not the maximal effect of (-)-CGP 12177 was reduced in right atrium from failing hearts, which was associated with 64% and 52% reductions in the densities of low-affinity and high-affinity (-)-[3H]CGP 12177 binding sites. In the presence of (-)-propanolol and 3-isobutyl-1-methylxanthine, (-)-CGP 12177 increased atrial cyclic AMP levels and activated cyclic AMP-dependent protein kinase in right atrium from non-failing hearts. In right ventricle from failing hearts (-)-CGP 12177 increased contractile force (–logEC50[M] 7.4±0.1, Emax 34±3%, n=13 patients) and hastened the time to peak force (–logEC50[M] 7.6±0.1) and time to reach 50% relaxation (–logEC50[M] 7.4±0.1) in the presence of (-)-propranolol and 3-isobutyl-1-methylxanthine. Our results show that (-)-CGP 12177 increases contractility and hastens relaxation through a cyclic AMP pathway in human myocardium, consistent with mediation through a (-)-propranolol-resistant state of the β1-adrenoceptor. The reduction in heart failure of atrial inotropic potency of (-)-CGP 12177, as well as of the high-affinity and low-affinity binding sites for (-)-[3H]CGP 12177, is consistent with the β1-adrenoceptor nature of these sites.
- Subjects
ADRENERGIC receptors; CATECHOLAMINES; ADENOSINE monophosphate; PHARMACOLOGY; BINDING sites; BIOCHEMISTRY
- Publication
Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, Vol 367, Issue 1, p10
- ISSN
0028-1298
- Publication type
Article
- DOI
10.1007/s00210-002-0652-9